D-0761-2026 Class II Ongoing
FDA drug recall D-0761-2026 was initiated by Shoolin Pharma Chem LLP on Aug 3, 2026 and is designated Class II. Reason for recall: CGMP Deviations:Noted during FDA inspection The recall status is ongoing. Affected quantity: 20 KG, 40 X 0.500KG(500gm) bags.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 19, 2026
- Initiation Date
- Aug 3, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20 KG, 40 X 0.500KG(500gm) bags
Product description
TADALAFIL USP, 0.500 KG, 0.500KG(500gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 171596-29-5), NDC 85702-002-04.
Reason for recall
CGMP Deviations:Noted during FDA inspection
Distribution pattern
Distributed Nationwide in the USA
Code information
Batch TLF2506001, Date of Expiry: May 31, 2028.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0761-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026